Antioxidant Activity, Inhibition of Intestinal Cancer Cell Growth and Polyphenolic Compounds of the Seagrass Posidonia oceanica's Extracts from Living Plants and Beach Casts

Alkistis Kevrekidou,Andreana N. Assimopoulou,Varvara Trachana,Dimitrios Stagos,Paraskevi Malea
DOI: https://doi.org/10.3390/md22030130
2024-03-12
Marine Drugs
Abstract:The aim of the present study was to investigate the use of Posidonia oceanica for making products beneficial for human health. Firstly, we demonstrated that the antioxidant defense (i.e., SOD and APX activity) of P. oceanica's living leaves (LP) has low efficacy, as they partly neutralize the produced H2O2. However, high H2O2 levels led LP to produce, as a response to oxidative stress, high phenolic content, including chicoric acid, p-coumaric acid, caftaric acid, trans-cinnamic and rutin hydrate, as shown by UHPLC-DAD analysis. In addition, LP extracts inhibited intestinal cancer cell proliferation. Moreover, P. oceanica's beach casts consisting of either Wet 'Necromass' (WNP) or Dry 'Necromass' (DNP) were used for preparing extracts. Both DNP and WNP exhibited antioxidant and antiproliferative activities, although lower as compared to those of LP extracts. Although both P. oceanica's meadows and beach casts are considered priority habitats in the Mediterranean Sea due to their high ecological value, legislation framework for beach casts forbidding their removal is still missing. Our results suggested that both LP and DNP could be utilized for the production of high-added value products promoting human health, provided that a sustainability management strategy would be applied for P. oceanica's meadows and beach casts.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The main issue this paper attempts to address is the potential of extracts from the live leaves (LP), wet necrotic leaves (WNP), and dry necrotic leaves (DNP) of the Mediterranean seagrass Posidonia oceanica in terms of antioxidant activity, inhibition of colon cancer cell proliferation, and polyphenolic compound content. Specifically, the study aims to: 1. **Evaluate antioxidant activity**: Assess the antioxidant performance of these extracts by measuring the activity of antioxidant enzymes (such as superoxide dismutase SOD and ascorbate peroxidase APX) and protein content, as well as their free radical scavenging capacity. 2. **Inhibit colon cancer cell proliferation**: Test the inhibitory effects of these extracts on the proliferation of human colon cancer cells to evaluate their potential anticancer effects. 3. **Analyze polyphenolic compounds**: Identify and quantify the polyphenolic compounds in these extracts, including chlorogenic acid, p-coumaric acid, and caffeic acid, using UHPLC-DAD technology. 4. **Resource management and utilization**: Based on the research results, propose sustainable management strategies for the partial utilization of the biomass of live and necrotic leaves of Posidonia oceanica to produce high-value health products, while minimizing negative impacts on the ecosystem. In summary, this study not only focuses on the bioactivity of Posidonia oceanica extracts but also considers how to reasonably manage and utilize this natural resource to promote human health.